Exploratory Biomarkers for Acute Rejection in Vascularized Composite Allotransplantation
Preprint
Abstract
Vascularized composite allotransplantation (VCA) involves immunologically heterogeneous tissues and is associated with high rates of acute rejection (AR), particularly due to the immunogenicity of the skin. This study assessed biomarkers to monitor AR in a recipient of full-face and bilateral hand transplantation. Over 4.6 years postoperatively, we analyzed serial blood and tissue samples, including donor-derived cell-free DNA (dd-cfDNA) in plasma, recipient DNA in allograft biopsies using short tandem repeat (STR) analysis, lymphocyte subsets via flow cytometry, and level of angiotensin II type 1 receptor antibodies (AT1R-Abs). dd-cfDNA and STR showed trends toward elevated recipient signal during acute rejection, though differences were not statistically significant. CD8+ T-cell percentages increased before AR onset, suggesting potential as a prognostic biomarker. AT1R-Ab levels did not differ significantly between AR and non-rejection episodes, possibly due to prophylactic immune cell depletion. While dd-cfDNA and STR levels correlate with rejection episodes and reflect key cellular events within graft tissue, CD8+ T-cell count remains the most robust prognostic biomarker for predicting the onset of cytotoxicity in this patient. These findings highlight the importance of further longitudinal, multi-patient studies to validate emerging biomarkers and improve rejection monitoring strategies in VCA.Keywords
This publication has 15 references indexed in Scilit:
- Clinical utility of plasma percent donor-derived cell-free DNA for lung allograft surveillance: A real-world single-center experienceJHLT Open, 2024
- Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changesAmerican Journal of Transplantation, 2024
- Minimally and Non-invasive Approaches to Rejection Identification in Vascularized Composite AllotransplantationTransplantation Reviews, 2023
- Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver TransplantationLiver Transplantation, 2021
- Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center ExperienceTransplantation, 2021
- Skin Immunology and Rejection in VCA and Organ TransplantationCurrent Transplantation Reports, 2020
- A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation OutcomeTransplantation, 2017
- Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsiesCardiovascular Pathology, 2015
- The International Registry on Hand and Composite Tissue TransplantationTransplantation, 2010
- Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft RejectionNew England Journal of Medicine, 2005